13 results
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
18 Apr 24
Regulation FD Disclosure
1:30pm
www.inmedpharma.com
InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer’s Expert,
to the Company’s Scientific Advisory Board
Vancouver, BC – April
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
29 Nov 23
Regulation FD Disclosure
2:50pm
a study, conducted under a collaborative research agreement with leading cannabinoid expert Dr. Mauro Maccarrone at the Università degli Studi … . Mauro Maccarrone
Dr. Mauro Maccarrone is an international expert in cannabinoid research working with the Department of Biotechnological and Applied
424B5
hchme4yth77yi6sabr3y
3 Jun 22
Prospectus supplement for primary offering
9:45pm
8-K
EX-99.1
y6rzn 88upsz
28 Apr 22
Regulation FD Disclosure
2:35pm
DEF 14A
nspri21n3q49v991eb
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-99.1
qckzwlw1
19 Jan 21
Regulation FD Disclosure
2:42pm
8-K
EX-1.1
abs91uzq 94r5ygp568e
12 Nov 20
InMed Announces Pricing of US$8M Public Offering and
10:15am
S-1/A
EX-1.1
204im
6 Jul 20
IPO registration (amended)
6:06am
- Prev
- 1
- Next